Robin Shane Readnour - 26 Nov 2024 Form 4 Insider Report for AN2 Therapeutics, Inc. (ANTX)

Role
Director
Signature
/s/ Eric Easom, Attorney-in-Fact for Robin Shane Readnour
Issuer symbol
ANTX
Transactions as of
26 Nov 2024
Net transactions value
+$105,685
Form type
4
Filing time
27 Nov 2024, 19:07:58 UTC
Previous filing
21 Nov 2024
Next filing
10 Dec 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANTX Common Stock Purchase $17,418 +12,500 +2.4% $1.39 527,288 26 Nov 2024 See Footnote F1, F2, F3
transaction ANTX Common Stock Purchase $17,428 +12,500 +2.1% $1.39 597,573 26 Nov 2024 See Footnote F2, F4, F5
transaction ANTX Common Stock Purchase $35,422 +25,000 +4.7% $1.42 552,288 27 Nov 2024 See Footnote F2, F3, F6
transaction ANTX Common Stock Purchase $35,418 +25,000 +4.2% $1.42 622,573 27 Nov 2024 See Footnote F2, F5, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $1.3767 to $1.41 per share. Upon request by the Commission staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares sold at each separate price.
F2 MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC Venture Partners 2018, LP ("MGC 2018 LP") and MGC Venture Partners QP 2018 LP ("MGC 2018 QP"). MGC 2018 GP has shared voting and shared dispositive power over the shares held by MGC 2018 LP and MGC 2018 QP. The Reporting Person is a member of the Issuer's board of directors and is a member of MGC 2018 QP and MGC 2018 LP and a managing partner of MGC 2018 GP and has shared voting power and shared dispositive power over the shares of common stock held by MGC 2018 LP and MGC 2018 QP. The Reporting Person disclaims beneficial ownership of the securities, except to the extent of such person's pecuniary interest in such securities.
F3 Shares held directly by MGC 2018 LP.
F4 This price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $1.38 to $1.409 per share. Upon request by the Commission staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares sold at each separate price.
F5 Shares held directly by MGC 2018 QP.
F6 This price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $1.36 to $1.44 per share. Upon request by the Commission staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares sold at each separate price.
F7 This price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $1.36 to $1.44 per share. Upon request by the Commission staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares sold at each separate price.